We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer

    Background

    Alternative RNA splicing is widely dysregulated in cancers including lung adenocarcinoma, where aberrant splicing events are frequently...

    April Lo, Maria McSharry, Alice H. Berger in BMC Cancer
    Article Open access 16 December 2022
  2. PARP inhibition leads to synthetic lethality with key splicing-factor mutations in myelodysplastic syndromes

    Background

    Splicing factors are frequently mutated in patients with myelodysplastic syndromes and acute myeloid leukaemia. Recent studies have...

    Fangliang Zhang, Jianai Sun, ... Liang Chen in British Journal of Cancer
    Article 28 May 2024
  3. Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia

    Background

    Alternative splicing (AS) of RNA is a fundamental biological process that shapes protein diversity. Many non-characteristic AS events are...

    Fang-Min Zhong, Fang-Yi Yao, ... **ao-Zhong Wang in Journal of Translational Medicine
    Article Open access 07 January 2023
  4. Characterization of a Novel F5 Intronic Variant Associated with Aberrant Splicing and Severe Factor V Deficiency

    Congenital factor V (FV) deficiency is a rare autosomal recessive bleeding disorder caused by defects in the F5 gene associated with bleeding...

    O. S. Pshenichnikova, E. V. Yakovleva, ... V. L. Surin in Russian Journal of Genetics
    Article 01 February 2023
  5. TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO

    Background

    Ubiquitination plays an important role in proliferating and invasive characteristic of glioblastoma (GBM), similar to many other cancers....

    Yike Chen, **aohui Xu, ... Jianmin Zhang in Journal of Experimental & Clinical Cancer Research
    Article Open access 02 February 2024
  6. Role of epithelial splicing regulatory protein 1 in cancer progression

    As aberrant alternative splicing by either dysregulation or mutations of splicing factors contributes to cancer initiation and progression, splicing...

    Mi Jeong Kwon in Cancer Cell International
    Article Open access 18 December 2023
  7. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

    Background

    Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer, requiring novel treatments to target both cancer cells and cancer stem...

    Emilia Alors-Perez, Ricardo Blázquez-Encinas, ... Justo P. Castaño in Journal of Experimental & Clinical Cancer Research
    Article Open access 02 December 2021
  8. Oncofetal SNRPE promotes HCC tumorigenesis by regulating the FGFR4 expression through alternative splicing

    Background

    Due to insufficient knowledge about key molecular events, Hepatocellular carcinoma (HCC) lacks effective treatment targets....

    Qipeng Wu, Ruyan Liao, ... Qinwei Yu in British Journal of Cancer
    Article 25 May 2024
  9. Genetic Mutations and Alternative Splicing in Schizophrenia

    Genetic mutations are responsible for most neurogenetic disorders. Schizophrenia is a neurogenetic disorder; we focused on genetic mutations and...
    Namrata Rambhau Jawanjal, Indranath Chatterjee in Cognizance of Schizophrenia:: A Profound Insight into the Psyche
    Chapter 2023
  10. Downregulation of HNRNPA1 induced neoantigen generation via regulating alternative splicing

    Background

    Immunotherapies effectively treat human malignancies, but the low response and resistance are major obstacles. Neoantigen is an emerging...

    Yaoqi Sun, Bing **ong, ... Shupeng Liu in Molecular Medicine
    Article Open access 12 June 2024
  11. Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis

    Background

    Dysregulation of alternative splicing (AS) triggers many tumours, understanding the roles of splicing events during tumorigenesis would...

    Sha Song, Weimin Zhang, ... Wenzhuo Zhuang in British Journal of Cancer
    Article 02 January 2023
  12. Biological relevance of alternative splicing in hematologic malignancies

    Alternative splicing (AS) is a strictly regulated process that generates multiple mRNA variants from a single gene, thus contributing to proteome...

    Monika Szelest, Krzysztof Giannopoulos in Molecular Medicine
    Article Open access 17 May 2024
  13. The role of alternative pre-mRNA splicing in cancer progression

    Alternative pre-mRNA splicing is a critical mechanism that generates multiple mRNA from a single gene, thereby increasing the diversity of the...

    Sunkyung Choi, Namjoon Cho, ... Kee K. Kim in Cancer Cell International
    Article Open access 24 October 2023
  14. SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis

    Background

    Aberrant alternative splicing (AS) is a pervasive event during colorectal cancer (CRC) development. SF3B3 is a splicing factor component of...

    Tong Xu, **chuan Li, ... Youcai Zhang in Journal of Experimental & Clinical Cancer Research
    Article Open access 26 April 2024
  15. Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma

    Background

    Hepatocellular carcinoma (HCC) accounts for a majority of primary liver cancer cases and related deaths. The purpose of this study was to...

    Ju A Son, Ji Hyang Weon, ... Soon Sun Kim in Journal of Experimental & Clinical Cancer Research
    Article Open access 30 October 2023
  16. Alternative splicing in neurodegenerative disease and the promise of RNA therapies

    Alternative splicing generates a myriad of RNA products and protein isoforms of different functions from a single gene. Dysregulated alternative...

    David Nikom, Sika Zheng in Nature Reviews Neuroscience
    Article 19 June 2023
  17. RNA splicing dysregulation and the hallmarks of cancer

    Dysregulated RNA splicing is a molecular feature that characterizes almost all tumour types. Cancer-associated splicing alterations arise from both...

    Robert K. Bradley, Olga Anczuków in Nature Reviews Cancer
    Article 10 January 2023
  18. Gene expression and alternative splicing contribute to adaptive divergence of ecotypes

    Regulation of gene expression is a critical link between genotype and phenotype explaining substantial heritable variation within species. However,...

    Peter A. Innes, April M. Goebl, ... Nolan C. Kane in Heredity
    Article 09 December 2023
  19. The implications of alternative pre-mRNA splicing in cell signal transduction

    Cells produce multiple mRNAs through alternative splicing, which ensures proteome diversity. Because most human genes undergo alternative splicing,...

    Sunkyung Choi, Namjoon Cho, Kee K. Kim in Experimental & Molecular Medicine
    Article Open access 03 April 2023
  20. Alternative splicing and environmental adaptation in wild house mice

    A major goal of evolutionary genetics is to understand the genetic and molecular mechanisms underlying adaptation. Previous work has established that...

    David N. Manahan, Michael W. Nachman in Heredity
    Article 27 November 2023
Did you find what you were looking for? Share feedback.